Natural product pharmacology: the British Journal of Pharmacology perspective

Xin Wang; Angelo A Izzo; Andreas Papapetropoulos; Steve P H Alexander; Miriam Cortese-Krott; Dave A Kendall; Kirill A Martemyanov; Claudio Mauro; Reynold A Panettieri; Hemal H Patel; Rainer Schulz; Barbara Stefanska; Gary J Stephens; Mauro M Teixeira; Nathalie Vergnolle; Péter Ferdinandy

doi:10.1111/bph.17300

Natural product pharmacology: the British Journal of Pharmacology perspective

Xin Wang^*
, Angelo A Izzo
, Andreas Papapetropoulos
, Steve P H Alexander
, Miriam Cortese-Krott
, Dave A Kendall
, Kirill A Martemyanov
, Claudio Mauro
, Reynold A Panettieri
, Hemal H Patel
, Rainer Schulz
, Barbara Stefanska
, Gary J Stephens
, Mauro M Teixeira
, Nathalie Vergnolle
, Péter Ferdinandy

^*Corresponding author for this work

Inflammation and Ageing

Research output: Contribution to journal › Editorial › peer-review

127 Downloads (Pure)

Abstract

Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications in this field. In this editorial review, we highlight key points from the 2020 British Journal of Pharmacology (BJP) practical guide, which outlines standards for natural products research reports, and provide papers published in BJP between years 2020 to 2023 that demonstrate adherence to these guidelines. Looking ahead, we discuss the potential of chemical proteomics approaches to elucidate natural products mechanisms of action and identify therapeutic targets for future research. By fostering innovation, we aim to advance natural products research and contribute to the development of novel therapeutics that will have a significant impact on healthcare.

Original language	English
Pages (from-to)	3547-3555
Number of pages	9
Journal	British Journal of Pharmacology
Volume	181
Issue number	19
Early online date	11 Aug 2024
DOIs	https://doi.org/10.1111/bph.17300
Publication status	Published - Oct 2024

Bibliographical note

Keywords

Animals
Humans
Biological Products/pharmacology
Drug Development
Periodicals as Topic
Pharmacology
Proteomics

Access to Document

10.1111/bph.17300Licence: Creative Commons: Attribution (CC BY)

WangX2024NaturalFinal published version, 1.8 MBLicence: Creative Commons: Attribution (CC BY)

Cite this

Wang, X., Izzo, A. A., Papapetropoulos, A., Alexander, S. P. H., Cortese-Krott, M., Kendall, D. A., Martemyanov, K. A., Mauro, C., Panettieri, R. A., Patel, H. H., Schulz, R., Stefanska, B., Stephens, G. J., Teixeira, M. M., Vergnolle, N., & Ferdinandy, P. (2024). Natural product pharmacology: the British Journal of Pharmacology perspective. British Journal of Pharmacology, 181(19), 3547-3555. https://doi.org/10.1111/bph.17300

@article{00978617e4924e6bacf44d53d652c5b2,

title = "Natural product pharmacology: the British Journal of Pharmacology perspective",

abstract = "Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications in this field. In this editorial review, we highlight key points from the 2020 British Journal of Pharmacology (BJP) practical guide, which outlines standards for natural products research reports, and provide papers published in BJP between years 2020 to 2023 that demonstrate adherence to these guidelines. Looking ahead, we discuss the potential of chemical proteomics approaches to elucidate natural products mechanisms of action and identify therapeutic targets for future research. By fostering innovation, we aim to advance natural products research and contribute to the development of novel therapeutics that will have a significant impact on healthcare.",

keywords = "Animals, Humans, Biological Products/pharmacology, Drug Development, Periodicals as Topic, Pharmacology, Proteomics",

author = "Xin Wang and Izzo, \{Angelo A\} and Andreas Papapetropoulos and Alexander, \{Steve P H\} and Miriam Cortese-Krott and Kendall, \{Dave A\} and Martemyanov, \{Kirill A\} and Claudio Mauro and Panettieri, \{Reynold A\} and Patel, \{Hemal H\} and Rainer Schulz and Barbara Stefanska and Stephens, \{Gary J\} and Teixeira, \{Mauro M\} and Nathalie Vergnolle and P{\'e}ter Ferdinandy",

note = "{\textcopyright} 2024 The Author(s). British Journal of Pharmacology published by John Wiley \& Sons Ltd on behalf of British Pharmacological Society.",

year = "2024",

month = oct,

doi = "10.1111/bph.17300",

language = "English",

volume = "181",

pages = "3547--3555",

journal = "British Journal of Pharmacology",

issn = "0007-1188",

publisher = "Wiley",

number = "19",

}

Wang, X, Izzo, AA, Papapetropoulos, A, Alexander, SPH, Cortese-Krott, M, Kendall, DA, Martemyanov, KA, Mauro, C, Panettieri, RA, Patel, HH, Schulz, R, Stefanska, B, Stephens, GJ, Teixeira, MM, Vergnolle, N & Ferdinandy, P 2024, 'Natural product pharmacology: the British Journal of Pharmacology perspective', British Journal of Pharmacology, vol. 181, no. 19, pp. 3547-3555. https://doi.org/10.1111/bph.17300

TY - JOUR

T1 - Natural product pharmacology

T2 - the British Journal of Pharmacology perspective

AU - Wang, Xin

AU - Izzo, Angelo A

AU - Papapetropoulos, Andreas

AU - Alexander, Steve P H

AU - Cortese-Krott, Miriam

AU - Kendall, Dave A

AU - Martemyanov, Kirill A

AU - Mauro, Claudio

AU - Panettieri, Reynold A

AU - Patel, Hemal H

AU - Schulz, Rainer

AU - Stefanska, Barbara

AU - Stephens, Gary J

AU - Teixeira, Mauro M

AU - Vergnolle, Nathalie

AU - Ferdinandy, Péter

PY - 2024/10

Y1 - 2024/10

N2 - Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications in this field. In this editorial review, we highlight key points from the 2020 British Journal of Pharmacology (BJP) practical guide, which outlines standards for natural products research reports, and provide papers published in BJP between years 2020 to 2023 that demonstrate adherence to these guidelines. Looking ahead, we discuss the potential of chemical proteomics approaches to elucidate natural products mechanisms of action and identify therapeutic targets for future research. By fostering innovation, we aim to advance natural products research and contribute to the development of novel therapeutics that will have a significant impact on healthcare.

AB - Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications in this field. In this editorial review, we highlight key points from the 2020 British Journal of Pharmacology (BJP) practical guide, which outlines standards for natural products research reports, and provide papers published in BJP between years 2020 to 2023 that demonstrate adherence to these guidelines. Looking ahead, we discuss the potential of chemical proteomics approaches to elucidate natural products mechanisms of action and identify therapeutic targets for future research. By fostering innovation, we aim to advance natural products research and contribute to the development of novel therapeutics that will have a significant impact on healthcare.

KW - Animals

KW - Humans

KW - Biological Products/pharmacology

KW - Drug Development

KW - Periodicals as Topic

KW - Pharmacology

KW - Proteomics

U2 - 10.1111/bph.17300

DO - 10.1111/bph.17300

M3 - Editorial

C2 - 39128855

SN - 0007-1188

VL - 181

SP - 3547

EP - 3555

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

IS - 19

ER -

Natural product pharmacology: the British Journal of Pharmacology perspective

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this